Medifast share price today

(MED)

Medifast share price is $17.76 & ₹1,514.40 as on 27 Dec 2024, 2.30 'hrs' IST

$17.76

▲

0.79

(4.66%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Medifast share price in Dollar and Rupees. Guide to invest in Medifast from India. Also see the sentimental analysis on Indian investors investing in Medifast. Get details on the Indian mutual funds that are investing in Medifast. Get Analyst recommendations and forecasts along with all the Medifast's financials.

Medifast share price movements

Today's Low: $16.95
Today's High: $17.80
$17.76
4.56%
Downside
Day's Volatility :4.78%
Upside
0.22%
52 Weeks Low: $16.70
52 Weeks High: $70.58
$17.76
5.97%
Downside
52 Weeks Volatility :76.34%
Upside
74.84%

Medifast Returns

Period	Medifast Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	-11.84%	-4.1%	0.0%
6 Months	-22.23%	2.8%	0.0%
1 Year	-75.09%	11.1%	0.0%
3 Years	-91.83%	5.6%	-21.1%

Medifast Key Statistics

in dollars & INR

Previous Close	$16.97
Open	$17.0
Today's High	$17.8
Today's Low	$16.95
Market Capitalization	$185.6M
Today's Volume	$101.0K
52 Week High	$70.58
52 Week Low	$16.7
Revenue TTM	$674.5M
EBITDA	$27.0M
Earnings Per Share (EPS)	$0.67
PE Ratio	25.33
Profit Margin	1.09%
Quarterly Earnings Growth YOY	-0.95%
Return On Equity TTM	3.66%

How to invest in Medifast from India?

It is very easy for Indian residents to invest directly in Medifast from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Medifast stock in both Indian Rupees (INR) and US Dollars (USD). Search for Medifast or MED on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Medifast or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Medifast shares which would translate to 0.048 fractional shares of Medifast as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Medifast, in just a few clicks!

Returns in Medifast for Indian investors in Rupees

Investment Value

₹1,00,000

Medifast investment value today

Current value as on today

₹28,393

Returns

₹71,607

(-71.61%)

Returns from Medifast Stock

₹73,932 (-73.93%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Medifast

-64%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Medifast on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -64% less investors are searching Medifast in the last 30 days versus the previous period.

Global Institutional Holdings in Medifast

Renaissance Technologies Corp
9.20%
BlackRock Inc
7.58%
Vanguard Group Inc
6.64%
AQR Capital Management LLC
3.52%
Morgan Stanley - Brokerage Accounts
2.93%
Bank of America Corp
2.88%

Analyst Recommendation on Medifast

Sell

0%Buy

44%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Medifast(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Medifast

What analysts predicted

Downside of 7.09%

Current:

$17.76

Target:

$16.50

Insights on Medifast

Price Movement
In the last 1 year, MED stock has moved down by -74.7%
Decreasing Revenue
Revenue is down for the last 7 quarters, 348.98M → 140.16M (in $), with an average decrease of 13.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -8.15M → 1.12M (in $), with an average increase of 822.2% per quarter
MED vs FTDR (1 yr)
In the last 1 year, Frontdoor Inc has given 57.4% return, outperforming this stock by 132.1%
MED vs HRB (3 yr)
In the last 3 years, H&r Block, Inc. has given 58.7% return, outperforming this stock by 150.4%
Price to Sales
ForMED every $1 of sales, investors are willing to pay $0.3, whereas for Frontdoor Inc, the investors are paying $2.4 for every $1 of sales.

Medifast Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$501.0M	↑ 66.14%
Net Income	$55.8M	↑ 101.25%
Net Profit Margin	11.14%	↑ 1.95%

	FY19	Y/Y Change
Revenue	$713.7M	↑ 42.45%
Net Income	$77.9M	↑ 39.66%
Net Profit Margin	10.92%	↓ 0.22%

	FY20	Y/Y Change
Revenue	$934.8M	↑ 30.99%
Net Income	$102.9M	↑ 32.01%
Net Profit Margin	11.0%	↑ 0.08%

	FY21	Y/Y Change
Revenue	$1.5B	↑ 63.25%
Net Income	$164.0M	↑ 59.47%
Net Profit Margin	10.75%	↓ 0.25%

	FY22	Y/Y Change
Revenue	$1.6B	↑ 4.75%
Net Income	$143.6M	↓ 12.48%
Net Profit Margin	8.98%	↓ 1.77%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 32.94%
Net Income	$99.4M	↓ 30.75%
Net Profit Margin	9.27%	↑ 0.29%

	Q2 FY23	Q/Q Change
Revenue	$296.2M	↓ 15.13%
Net Income	$30.3M	↓ 24.24%
Net Profit Margin	10.22%	↓ 1.23%

	Q3 FY23	Q/Q Change
Revenue	$235.9M	↓ 20.37%
Net Income	$23.1M	↓ 23.61%
Net Profit Margin	9.81%	↓ 0.41%

	Q4 FY23	Q/Q Change
Revenue	$191.0M	↓ 19.02%
Net Income	$6.0M	↓ 73.91%
Net Profit Margin	3.16%	↓ 6.65%

	Q1 FY24	Q/Q Change
Revenue	$174.7M	↓ 8.52%
Net Income	$8.3M	↑ 37.8%
Net Profit Margin	4.76%	↑ 1.6%

	Q2 FY24	Q/Q Change
Revenue	$168.6M	↓ 3.54%
Net Income	$-8.2M	↓ 198.05%
Net Profit Margin	-4.84%	↓ 9.6%

	Q3 FY24	Q/Q Change
Revenue	$140.2M	↓ 16.85%
Net Income	$1.1M	↓ 113.85%
Net Profit Margin	0.81%	↑ 5.65%

	FY18	Y/Y Change
Profit	$379.9M	↑ 66.76%

	FY19	Y/Y Change
Profit	$536.9M	↑ 41.32%

	FY20	Y/Y Change
Profit	$697.8M	↑ 29.98%

	FY21	Y/Y Change
Profit	$1.1B	↑ 61.59%

	FY22	Y/Y Change
Profit	$1.1B	↑ 1.14%

	FY23	Y/Y Change
Profit	$775.9M	↓ 31.97%

	Q2 FY23	Q/Q Change
Profit	$210.7M	↓ 14.48%

	Q3 FY23	Q/Q Change
Profit	$177.4M	↓ 15.82%

	Q4 FY23	Q/Q Change
Profit	$141.4M	↓ 20.3%

	Q1 FY24	Q/Q Change
Profit	$127.3M	↓ 9.96%

	Q2 FY24	Q/Q Change
Profit	$123.4M	↓ 3.03%

	Q3 FY24	Q/Q Change
Profit	$105.7M	↓ 14.39%

	FY18	Y/Y Change
Operating Cash Flow	$60.8M	↑ 40.66%
Investing Cash Flow	$-1.2M	↓ 62.09%
Financing Cash Flow	$-53.3M	↑ 207.15%

	FY19	Y/Y Change
Operating Cash Flow	$84.3M	↑ 38.55%
Investing Cash Flow	$-6.3M	↑ 427.77%
Financing Cash Flow	$-82.3M	↑ 54.37%

	FY20	Y/Y Change
Operating Cash Flow	$145.2M	↑ 72.32%
Investing Cash Flow	$-1.3M	↓ 79.74%
Financing Cash Flow	$-57.1M	↓ 30.59%

	FY21	Y/Y Change
Operating Cash Flow	$94.5M	↓ 34.88%
Investing Cash Flow	$-29.1M	↑ 2167.08%
Financing Cash Flow	$-125.1M	↑ 118.98%

	FY22	Y/Y Change
Operating Cash Flow	$194.6M	↑ 105.8%
Investing Cash Flow	$-11.4M	↓ 60.73%
Financing Cash Flow	$-199.6M	↑ 59.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$43.1M	↓ 32.65%
Investing Cash Flow	$-1.7M	↓ 17.54%
Financing Cash Flow	$-17.8M	↓ 31.13%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$29.9M	↓ 30.63%
Investing Cash Flow	$-50.3M	↑ 2785.09%
Financing Cash Flow	$-18.2M	↑ 1.78%

Medifast Technicals Summary

Sell

Neutral

Buy

Medifast is currently in a neutral trading position according to technical analysis indicators.

Medifast Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Medifast Inc	-12.71%	-22.23%	-75.09%	-91.83%	-84.37%
Service Corporation International	-8.46%	13.62%	17.81%	15.03%	75.12%
Frontdoor Inc	-3.67%	67.15%	59.86%	54.06%	20.35%
Bright Horizons Family Solutions Inc	-4.69%	-0.35%	14.68%	-12.04%	-20.69%
H&r Block, Inc.	-8.89%	0.11%	10.95%	130.04%	132.31%
Rollins Inc.	-9.67%	-4.49%	6.47%	39.02%	112.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Medifast Inc	25.33	25.33	1.95	1.77	0.04	0.05	NA	19.47
Service Corporation International	23.56	23.56	1.67	3.52	0.31	0.03	0.01	11.22
Frontdoor Inc	18.7	18.7	NA	3.19	1.08	0.19	NA	3.44
Bright Horizons Family Solutions Inc	54.85	54.85	1.76	3.4	0.09	0.04	NA	24.07
H&r Block, Inc.	13.51	13.51	0.54	4.3	0.98	0.19	0.03	-2.69
Rollins Inc.	48.04	48.04	3.19	0.99	0.39	0.15	0.01	2.72

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Medifast Inc	Sell	$185.6M	-84.37%	25.33	1.09%
Service Corporation International	Buy	$11.7B	75.12%	23.56	12.19%
Frontdoor Inc	Buy	$4.3B	20.35%	18.7	12.81%
Bright Horizons Family Solutions Inc	Buy	$6.4B	-20.69%	54.85	4.44%
H&r Block, Inc.	Buy	$7.4B	132.31%	13.51	16.19%
Rollins Inc.	Buy	$22.6B	112.59%	48.04	14.18%

About Medifast

since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better

Organization	Medifast
Employees	634
CEO	Mr. Daniel R. Chard
Industry	Retail Trade

Management People of Medifast

Name	Title
Mr. Daniel R. Chard	Executive Chairman & CEO
Mr. James P. Maloney CPA	Chief Financial Officer
Mr. Anthony E. Tyree	Chief Business Operations Officer
Mr. Jason L. Groves Esq.	Executive VP, General Counsel & Corporate Secretary
Mr. Nicholas M. Johnson	Chief Field Operations Officer
Mr. Steven Zenker	Vice President of Investor Relations
Ms. Claudia C. Greninger	Chief Human Resources Officer

Important FAQs about investing in Medifast from India :

What is Medifast share price today?

Medifast share price today stands at $17.76, Open: $17.00 ; Previous Close: $16.97 ; High: $17.80 ; Low: $16.95 ; 52 Week High: $70.58 ; 52 Week Low: $16.70. The stock opens at $17.00, after a previous close of $16.97. The stock reached a daily high of $17.80 and a low of $16.95, with a 52-week high of $70.58 and a 52-week low of $16.70.

Can Indians buy Medifast shares?

Yes, Indians can invest in the Medifast (MED) from India.

With INDmoney, you can buy Medifast at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Medifast at zero transaction cost.

How can I buy Medifast shares from India?

It is very easy to buy Medifast from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Medifast be purchased?

Yes, you can buy fractional shares of Medifast with INDmoney app.

What are the documents required to start investing in Medifast stocks?

To start investing in Medifast, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.